AP

Alex Pasteur

Director at Owkin

Alex Pasteur is currently the Director at Owkin. Prior to this, they were the Founding CEO at Orchard Therapeutics from December 2015 to November 2018. Orchard is a gene therapy company that develops treatments for patients with immuno-deficiencies and inherited metabolic diseases. Alex has also been a Partner at F-Prime Capital Partners and a Board Observer at Pulmocide.

Alex Pasteur earned a PhD in Chemistry from the University of Cambridge. Alex also holds a Master of Arts in Natural Sciences from the University of Cambridge.

Timeline

  • Director

    Current role